The PRISM study included a meaningful number of respondents across seven European countries, providing important insights to tailor disease ... of SM and other clonal mast cell diseases ...

Next steps include the production of more mitochondrial disease-free egg cells and the generation of healthy progeny in an animal model. The research was conducted in the New York Stem Cell ...

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached ...

Outcomes of patients with multiple myeloma treated at a regional Australian center compared to a metropolitan Australian center. Testing Mayo Clinic’s new 20/20/20 risk stratification model in another ...

Leukopenia is a condition where you have an abnormally low number of white blood cells (called leukocytes) due to an infection, malnutrition, autoimmune disease, drug side effects, bone marrow ...